We can extrapolate adverse effects of these compounds from those of AChE inhibitors used in Alzheimer’s disease treatment and medications used for smoking cessation (nicotine replacement therapy and varenicline). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.